Serum Beta-2 Microglobulin as a Predictive Marker of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus

Background: Early detection of diabetic nephropathy (DN) remains a clinical challenge, particularly in patients with type 2 diabetes mellitus (T2DM). Serum beta-2 microglobulin (B2M) has emerged as a potential biomarker for early renal impairment. Objective: This study aims to evaluate the utility...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Jamila Elamouri, Hazem Ayoub, Medhat Abd Elghaffar, Alsayed Rashed
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Al-Azhar University, Faculty of Medicine 2026-01-01
Цуврал:	Al-Azhar International Medical Journal
Нөхцлүүд:	Chronic Kidney Disease Type 2 diabetic nephropathy β2-microglobulin
Онлайн хандалт:	https://aimj.journals.ekb.eg/article_486646_e2b5cb19742c88d7bcf0df66d17e294b.pdf
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!